计算溶液所需的质量、体积或浓度。
| 活性类型 | 活性值-log(M) | 作用机制 | 期刊 | 参考文献(PubMed IDs) |
|---|
Moligand™ 级 提供 ≥99% 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。
-20°C储存。超低温运输 。请查阅批次 COA 获取详细规格。
SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。
在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。
Information
Tenalisib (RP6530) is a potent and selective dualPI3Kδ/γinhibitor withIC50values of 24.5 nM and 33.2 nM for PI3Kδ and PI3Kγ, respectively. Its selectivity over α and β isoforms are more than 300-fold and 100-fold, respectively.
Targets
PI3Kδ (Cell-free assay); PI3Kγ (Cell-free assay) 24.5 nM; 33.2 nM
In vitro
RP6530 is a specific dual PI3K δ/γ inhibitor exhibiting several-fold selectivity against the other PI3K isoforms and 245-kinases. RP6530 causes a dose-dependent inhibition (>50% @ 2-7 μM) in growth of immortalized (Raji, TOLEDO, KG-1, JEKO, REC-1) B-cell lymphoma cells. Effect is more pronounced in the DLBCL cell lines, OCI-LY-1 and OCI-LY-10 (>50% inhibition @ 0.1-0.7 μM), and the reduction in viability is accompanied by corresponding inhibition of pAKT with EC50 of 6 & 70 nM respectively. Treatment of patient-derived primary cells with 4 µM RP6530 causes an increase in cell death. Cells in early apotosis (Annexin V+/PI-) are not different between the DMSO blank and RP6530 samples. RP6530 shows potent inhibitory effect on cancer stem cells in ovarian cancer cell lines. Treatment with 1 μM RP6530 results in G2/M arrest in MM-1S and MM-1R lines with very few cells in the SubG0 phase. It also results in a 70−90% inhibition of pAKT in MM-1S and MM-1R cell lines. Potent modulation of inflammatory response by RP6530 contributes to control tumor microenvironment.
In vivo
The predicted T1/2, Cmax, and AUC0-t at 10 mg dose in human are 9.5 h, 14.0 μM, and 342.0 μM respectively. RP6530 has an excellent pharmacokinetic profile with plasma concentrations reaching well above the EC75 at doses as low as 3 mg/kg in rat and dog for 6-12 h. In addition, RP6530 shows >70 and >100% oral bioavailability with a half-life of 2 and 3 h in rat and dog respectively.
Cell Research(from reference)
Cell lines:MM cell lines, namely, MM-1S and MM-1R
Concentrations:1 μM
Incubation Time:72 h
分类树(Taxonomy Tree)
| 界(kingdom) | 有机化合物 |
|---|---|
| 超类(Superclass) | 苯丙素类和聚酮类 |
| 类(Class) | 异黄酮类化合物 |
| 亚类(Subclass) | 异黄-2-烯 |
| 中间层级节点(Intermediate Tree Nodes) | 暂无 |
| 直接上位类(Direct Parent) | 异黄酮 |
| 其他上位类(Alternative Parents) | 6-烷基氨基嘌呤 色酮 吡喃酮及其衍生物 氨基嘧啶及其衍生物 氟苯类 芳基氟化物 咪唑内酰胺类 咪唑类 杂芳族化合物 氧环化合物 氮杂环化合物 碳氢化合物衍生物 有机氧化物 有机氟化物 胺类 有机氧化合物 |
| 分子骨架(Molecular Framework) | 芳香族杂多环化合物 |
| 取代基(Substituents) | 1-苯并吡喃 - 6-烷基氨基嘌呤 - 6-氨基嘌呤 - 氨基酸 - 氨基吡啶 - 芳香族杂多环化合物 - 芳基氟化物 - 芳基卤化物 - 氮杂环 - 吡唑 - 苯基化合物 - 苯并吡喃 - 苯并吡喃 - 氟萘 - 卤苯 - 杂芳香族化合物 - 烃衍生物 - 咪唑 - 咪唑哌啶 - 咪唑内酰胺 - 异黄酮 - 单环苯基基团 - 有机硝基化合物 - 有机氧化物 - 有机氧化合物 - 有机氟化物 - 有机卤化物 - 有机杂环化合物 - 有机氮化合物 - 有机氧化合物 - 氧杂环 - 鸟苷酸 - 吡喃 - 吡喃酮 - 嘧啶 |
| 描述(Description) | 该化合物属于异黄酮类有机化合物。这类多环化合物具有2-异黄酮骨架,其C4碳原子上带有酮基团。 |
| 外部描述符(External Descriptors) | 暂无 |
| IC50 | PI3Kδ, IC50: 24.5 nM |
|---|---|
| ALogP | 4.07 |
| HBD Count | 2 |
| Rotatable Bond | 5 |
| 作用机制 | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | 参考文献 |
|---|
H302: 吞食有害
H315: 引起皮肤刺激
H319: 引起严重眼睛刺激
H335: 可能引起呼吸道刺激
P261: 避免吸入灰尘/烟雾/气体/雾/蒸汽/喷雾
P305+P351+P338: 如进入眼睛:用水小心冲洗几分钟。如戴隐形眼镜并可方便地取出,取出隐形眼镜。继续冲洗。